Professional Services · Pricing Negotiation Call
Professional Services Pricing Negotiation Script: Holding Your Number With a Managing Partner Who Bills $750 an Hour
The technical win is done. Their Director of Resource Management ran the pilot on two practices, the Head of Knowledge Management confirmed the retrieval actually surfaces the 2022 supply-chain diagnostic instead of eleven folders called "FINAL v7 - JG edits," and the Chief Operating Officer has already told the Managing Partner this is the pick. Nobody on this call is trying to talk themselves out of buying. They are trying to buy exactly this, for less.
What makes a professional services firm different in a pricing negotiation is that the person on the phone often can't sign and genuinely doesn't control the money. Each practice runs its own P&L. The COO is negotiating on behalf of twelve partners who don't report to them, at least three of whom will say "if it doesn't drive billable hours, why are we funding it." So the pushback arrives dressed as consensus-management rather than hardball: "I can get this through, I just need a number I can defend in the partners' meeting." That is a negotiation tactic. A polite, reasonable-sounding, extremely effective one.
This Professional Services pricing negotiation script is built for that call. The core discipline: stop selling, move scope instead of price, and never let anything leave your side of the table without a named item coming back — a term, a prepay, a signature date, a sanitized case study with a risk-partner approval path. And remember the leverage you actually have: they've burned six to fourteen weeks and real political capital telling their leadership it's you. Restarting an eval is unbillable partner time, and unbillable partner time is the one thing this firm genuinely cannot afford.
The pricing negotiation call script
Say it in your own words. The structure is the part that matters.
- 1
Before you dial: write down three numbers and your trade list
Do not open this call without these on paper. ASK: what's on the quote — say $216K/yr for the firm-wide license, 200 fee earners, seven practices. TARGET: where you honestly expect to land — say $195K with a 24-month term. FLOOR: $175K, and only with VP approval plus a signed case-study clause. Below $160K you walk. If you don't set the floor before the call, the floor becomes wherever the COO stops pushing. What you can give (each one costs you less than margin): - Discount points - Deferred start aligned to their fiscal year / partner comp year - Implementation and content-ingestion fees waived (loading their past SOWs and closeout decks) - A second practice added at no charge in year one - Ramped year-one pricing tied to practice rollout - 5% renewal uplift cap - Named executive sponsor and quarterly review with the practice heads What you must ask for in return: - 24 or 36-month term - Annual invoice up front rather than quarterly - Signature by a specific date, named - A sanitized case study — no client names, firm logo, a named spokesperson (Chief Growth Officer or the practice head), inside 120 days - Two reference calls, and you specify to whom - Removal of custom MSA redlines and uncapped liability - A warm intro to the sister practice or the international arm Also know: does the Managing Partner sign or does the COO have delegated authority up to a threshold? Is General Counsel or the risk partner already engaged on the data question? Is the partner compensation year ending — because partners who want a cost off this year's books are a lever pointed at them, not at you.
- 2
First 90 seconds: make them re-state the yes before they anchor
"Before we get anywhere near commercials — last week you told me the practice heads who ran the pilot are aligned that this is the direction, and that you'd already flagged it to [Managing Partner]. I just want to make sure I'm building the right paperwork. Is that still where you are?" Wait for the yes. Make them say it out loud. It is materially harder to threaten to walk twenty minutes after confirming you've won. Then: "Good. So this isn't a sales call anymore, it's a structuring call. Tell me what has to be true — number, term, paper — for [Managing Partner] to sign this, and I'll tell you honestly what I can and can't build."
- 3
Restate the business case in their numbers, not your features
You are not justifying the price. You are establishing the ratio the discount gets measured against — and then you stop talking about product entirely. "Just so we're measuring against the same thing. When [Director of Resource Management] pulled the pilot data, two numbers came out. First, unbillable pursuit hours per closed deal — you were at [X] across the two practices, mostly senior managers and partners rebuilding the same methodology section. Second, RFP receipt to proposal submitted, averaging [Y] days firm-wide, and your own win rate is meaningfully higher on anything you get out inside five days. At your blended rate, the pursuit hours alone are the number [CFO] would care about, and that's before the win-rate side. The proposal on the table is $216K. That's the shape of the deal. So — what needs to happen to get it signed?" Then shut up. Do not add a feature. Do not add "and there's some flexibility." Re-selling here is a discount they didn't have to ask for.
- 4
The low anchor: "Honestly, we budgeted about half that"
Do not counter. Do not react to the number. Get curious about how it was built — because in a partnership, "budgeted" can mean four different things. "Help me understand how you got to $90K. Is that a line finance has already approved, or is it what you think the practice heads will stomach in the partners' meeting? Those are really different problems and I'd solve them differently." Follow-ups worth having ready: - "Is this coming out of firm overhead, or is it getting allocated across practice P&Ls?" - "Which practice is paying the biggest share, and have they seen the pilot numbers?" - "If it lands in overhead, whose number does it damage — is that [CFO] or is that [Managing Partner]'s originations conversation?" A COO who says "it's allocated across seven practices and two of them haven't seen the pilot" has just told you the real problem is internal selling, not price. That's solvable without margin.
- 5
The most important move on the call: when they push price, you move scope
Never move price alone. Move what they're buying. "I can absolutely build you something at $90K. It won't be this. That's two practices, not seven — call it the ones that ran the pilot — no historical ingestion beyond what we already loaded, and firm-wide retrieval doesn't happen because six practices' worth of prior SOWs aren't in it. Here's my worry with that, honestly: the whole argument you made internally was that a manager in Ops Strategy should be able to find the pricing assumptions from the diagnostic the Healthcare practice ran in 2022. Two practices doesn't do that. But it's a real option and I'll price it today if you want it. Do you want me to scope that, or do we work on how to get the full thing funded?" Most of the time they don't want the small version — they want the full version cheaper. Making them look directly at the small version is what stops that.
- 6
The competitor quote
Assume it's real. Assume it isn't the same thing. "That's a real number, I believe you. Can you send me the quote? Not to match it — I want to see what's actually in it. When we've seen their pricing it's usually seats only, with ingestion of prior engagement material priced separately, and that's the part that took your pilot from interesting to useful." Then the question that decides the rest of the call: "Let me ask you straight. If they were free, would you still be buying them?" Nine times out of ten you get a version of "no, honestly, yours came out ahead on retrieval." That sentence is your leverage for the next thirty minutes, and you can refer back to it warmly: "I'm working from what you said earlier — that if theirs were free you still wouldn't take it." Never say "they're cheaper because they're worse." Say what's not in the quote and what that costs in unbillable hours later.
- 7
The case-study trade — and the confidentiality wrinkle that comes with it
Professional services firms dangle their logo like it's currency. It is currency. So price it, and know that this industry has a genuine reason to renege later. "I'd genuinely value that, and I'll pay for it. So let's make it real rather than a handshake. Five points off in exchange for: firm logo, a named quote from [Chief Growth Officer] or one of the practice heads, and one recorded conversation inside 120 days of go-live — written into the order form. And because I know how this works at a firm your size: no client names, no engagement details, everything sanitized, and I'll route the draft through your risk partner or General Counsel before anything goes out. Who's the approver — is that GC, or does marketing handle it?" If they can't name an approver and a date, the five points come off the table — warmly. "That's completely fine. Let's leave the case study out then, and I'll keep the number where it is." Accepting "we'd be happy to be a reference" as payment is how you end up in month seven with a permanent discount and nothing to show anyone.
- 8
The delay threat: "We might pick this up after the partners' retreat"
In this industry the delay threat is unusually credible — partner comp years, budget freezes, retreats — which is exactly why you must test it rather than pay for it. "That's your call and I'll still be here. Let me just think out loud with you, though. [Director of Resource Management] built the Q1 staffing plan partly around this landing in January — the two seniors she'd pulled off pursuit support go back on the bench if it slips. And the RFP calendar doesn't move; you've got the two big renewals coming through in the spring, which are the pursuits where turnaround actually decides it. What happens to those?" Then offer structure, not margin: "If the issue is cash timing rather than the decision — and if it's the freeze, say so — I can do a deferred start. Sign this month at this number, first invoice 1 April, so it lands in the new fiscal year and off this year's partner P&Ls. That gets you the price on the table and the cost in the quarter you want it. Does that solve it, or is the problem something else?" That costs you nothing and solves what is usually the actual problem: a partnership that doesn't want the hit on this year's distributions.
- 9
The silence after they name a number
They say "$150K and I can get it through" and then stop talking. This is where deals leak margin. The rule: you may not improve your own offer twice in a row. After they go quiet you have exactly two moves — say nothing, or ask a question. You may not say a number. Count to seven. Then: "...What's your reaction if I say I can't do that?" Or, if you have to speak, speak about process: "Set the number aside for a second. Once we've agreed it, what's the path? Does [Managing Partner] sign, or does it go through the executive committee? Is GC already looking at the paper?" The pause was the tactic. Don't buy it.
- 10
The concession ladder
Every discount must be smaller than the last, traded for something named, and explained. Bad: 15% → 20% → 25%. You've taught them each ask is worth five points. Good: 8% for a 24-month term → 11% for annual invoice up front → 12% for signature by the 27th, final. Say it like this every time: "I can get to 11%, and here's what I need to justify it internally — annual up front rather than quarterly. I know your instinct is to protect cash, given where lockup sits. But that's the trade. If you can do it, I take it to my VP today. If you can't, I'm at 8% and I'm comfortable there." Conditional, and someone else's decision. That's what lets you say no without being the person saying no. And discount the implementation and ingestion fees before you discount the platform line — the platform line is your renewal baseline two years from now.
- 11
Using the escalation card once, properly
"Let me check with my manager" is a tool, not a stall. Use it to buy a trade. "$150K is outside anything I can sign, and I don't want to pretend otherwise. I can take it to our VP — but I can't walk in with a request, I need to walk in with an argument. If it's 36 months, invoiced annually, and the case study is in the order form with a date on it, I've got something to say. Give me that and I'll go fight for it." Use it once. When you come back, come back final and say why it's final: "He signed off at $189K on the 36-month. He was very clear that's tied to the term and the date — if either moves it goes back for re-approval."
- 12
Landing it: confirm out loud, in writing within the hour
"So let me say it back. $189K a year, 36-month term, invoiced annually in advance, first invoice 1 April with a deferred start. Implementation and historical ingestion waived — that's all seven practices' prior SOWs and closeout decks. Renewal uplift capped at 5%. On your side: sanitized case study with [Chief Growth Officer] quoted, inside 120 days of go-live, routed through your risk partner before publication. Two reference calls. And [Managing Partner] signs by the 27th. Have I got that right? I'll have the revised order form to you within the hour, and I'll put fifteen minutes in Thursday to confirm GC is clear on the paper. And to be straight with you — this number is tied to that term and that date. If the 27th moves, I have to take it back for re-approval, and I'd rather tell you that now than surprise you in three weeks." Throughout: you are on their side of the table, arguing with your own company on their behalf. "I want to get this done." "Let me see what I can build." "I'll go fight for that." A firm no delivered warmly gets respected. A soft yes delivered nervously gets pushed a fourth time.
How the call actually sounds
Prospect on the left, the rep on the right.
Rep
Before we get into numbers — last week you said the practice heads who ran the pilot were aligned and you'd flagged it to Alan. Is that still where you are?
Buyer
It is. Ops Strategy and Healthcare both want it, and the Head of KM has been fairly evangelical, which is new for him. So yes, you've won it. The problem is the partners' meeting on the 21st. I've got twelve people in that room who each bill north of seven hundred an hour, none of whom report to me, and I need a number I can defend. Honestly, we budgeted about half of what's on your quote. Ninety.
Rep
Okay. Help me understand how you got to ninety — is that a line the CFO has already approved, or is it what you think the room will stomach on the 21st?
Buyer
Bit of both. It gets allocated across seven practice P&Ls, so every practice head sees their share as a hit on their margin. Utilization's already down about five points on the year — consultants are running low seventies against a seventy-five to eighty target — and two of the practices haven't even seen the pilot output. They'll just see a cost against a bench problem.
Rep
That's useful, because that's not really a price problem, it's an allocation problem. Let me ask it the other way. I can build you something at ninety. It's two practices, not seven — Ops Strategy and Healthcare — no ingestion beyond what we already loaded for the pilot. Which means when a manager in Financial Services is scoping a diagnostic, none of the prior work is in there. That was the whole argument you made internally. Do you want me to price that version, or do we work on how to fund the full one?
Buyer
I don't want the two-practice version, no. But I should tell you we've also got a quote from the other vendor. It's a hundred and ten firm-wide.
Rep
I believe you — send it over, I'd genuinely like to see it. Not to match it. When we've seen their pricing it's seats only, and loading historic SOWs and closeout decks is a separate services line that shows up later. But let me ask you straight: if theirs were free, would you still be buying them?
Buyer
…No. Their retrieval fell over on the older material and the KM lead wrote a fairly brutal note about it. But I can't take 'it's better' into a partners' meeting during a freeze. What I can do is help you — we're a recognisable name in this sector. Give us a real number and you can use us in your marketing.
Rep
I'd value that, and I'll pay for it — so let's make it real rather than a handshake. Five points, in exchange for the firm logo, a named quote from your Chief Growth Officer, and one recorded conversation inside a hundred and twenty days of go-live, written into the order form. Fully sanitized, no client names, and I'll route the draft through your risk partner before anything is published. Who's the approver — GC, or marketing?
Buyer
That's where it gets awkward. GC will not let us be named as using AI on anything touching client work — a few of our MSAs have clauses that make the risk partner nervous. We could do reference calls, unattributed. And look, let's be practical: a hundred and fifty and I'll carry it into the 21st myself.
Rep
Understood on GC — then let's take the case study out entirely rather than pretend, and the five points come out with it. On a hundred and fifty…
Buyer
…
Rep
What's your reaction if I tell you I can't do that number?
Buyer
My reaction is that we probably wait. The partner comp year closes in March, nobody wants a new line on this year's books, and the retreat's in April anyway. It's not a no, it's a not-now.
Rep
That's your call and I'll still be here. Let me just think out loud, though. Dana built the Q1 staffing plan around this landing in January — the two seniors she pulled onto pursuit support go back to the bench if it slips, which is more bench days on a number that's already sliding. And your two big renewals are in the spring; those are exactly the ones where RFP-to-submission decides it. But if the real issue is that nobody wants the cost on this year's P&L, that's a structure problem, not a price problem. Sign this month, first invoice 1 April. The cost lands in the new year, off every practice head's current number. Does that solve it?
Buyer
That helps more than you probably realise. Okay. Meet me in the middle then — call it one-seventy-five and I'll stop.
Rep
I'm not going to split the difference, because that's not a number I can defend upstairs any more than you can defend two-sixteen downstairs. Here's what I can do. Two-sixteen is list on twelve months. Eight points off for a twenty-four month term. Eleven if it's thirty-six and invoiced annually in advance. That's a hundred and eighty-nine, deferred start 1 April, implementation and full ingestion across all seven practices waived, renewal uplift capped at five percent. Eleven points is outside what I can sign, so I'd be taking it to my VP — and I can't walk in with a request, I need an argument. Give me the thirty-six months and I'll go fight for it today.
Buyer
Thirty-six is a long time for a partnership. But with ingestion waived across all seven, I can frame it to the room as one practice's worth of unbillable pursuit hours. Get me one-eighty-nine approved and I'll put it in front of Alan.
Rep
Then let me say it back. One-eighty-nine a year, thirty-six months, annual in advance, first invoice 1 April. Ingestion and implementation waived, all seven practices. Five percent uplift cap. Two unattributed reference calls from you, no case study. Alan signs by the 27th. Right?
Buyer
That's right, subject to GC on the data-handling language. He'll have redlines.
Rep
Good — send me his redlines by Wednesday and I'll get them in front of our counsel the same day. Revised order form to you within the hour. One thing so it isn't a surprise later: this number is tied to the thirty-six months and the 27th. If the date moves, it goes back for re-approval. I'd rather tell you that now than in three weeks.
Objections you will hear
What they say, and what you say back.
| Objection | How to answer it |
|---|---|
| “"I can't defend a line item that doesn't drive billable hours. Partners will ask what chargeable work it produces."” | Agree with the frame and use it. "You're right, and I wouldn't fund it either if it were overhead. It isn't — it's a utilization line. The hours your senior managers spent rebuilding the qualifications section and hunting for the analogous engagement are hours that couldn't go to a client code. So: how many unbillable pursuit hours went into pursuits last quarter in Ops Strategy alone, and what's a third of those worth at your blended rate?" Then make it one partner's number instead of a firm number — measure pursuit hours in the practice that ran the pilot before and after, and let that practice head walk it into the partners' meeting themselves. A number a partner owns survives the room; a number the COO owns gets debated. |
| “"At that price we'd just build it ourselves. We've got people on the bench and they're already paid for."” | Don't laugh at it — some firms genuinely try. "You could, and the bench cost is sunk, I take that. Two questions before you do. First, who maintains it in eighteen months when the analysts who built it are staffed on client work and the person who wrote the ingestion logic has gone to industry — because that's exactly how the last KM system ended up. Second, what does that team not do while they build it? Bench people going into IP development is how the utilization picture stops being accurate in the first place." Then move scope, not price: offer to hold the number and phase the rollout by practice instead. |
| “"We already paid for a knowledge management platform nobody opens. I'm not signing a second one at this price."” | "That's the strongest argument for doing this properly, not for paying less. Your KM system failed because it asked billable people to do unbillable filing — what percentage of engagements actually get a closeout deliverable uploaded today? Whatever the answer is, that's the ceiling on anything that depends on people volunteering time. The difference here is capture happens as a byproduct of work that's already happening, and retrieval happens inside the proposal moment rather than requiring someone to go browse a portal at 9pm." Then price-protect: "If the worry is buying the same failure twice, let's write an adoption milestone into the order form rather than take it out of the number." |
| “"General Counsel won't approve the case study — some of our MSAs prohibit any disclosure, and the risk partner is nervous about AI touching client material."” | Take it seriously; this is a real conflicts question, not a stalling tactic. "Completely fair, and I'd rather build the agreement around that than argue with your GC. Two things: no client is ever named, and I'll route any draft through your risk partner before publication. But if it genuinely can't happen, let's take the case study out of the deal entirely — and the points that were attached to it come out with it. What I'd swap in instead: two reference calls, unattributed, to firms of a similar size, and an intro to your international arm." Never let the confidentiality objection quietly delete your side of the trade while their discount survives. |
| “"We're in a freeze. Utilization is down five points and we're not adding spend this quarter."” | "Then the freeze is the reason to talk, not the reason not to. Bench time is capacity you're already paying for — the question is whether it's going into pursuits that close, or into internal initiatives that make the staffing picture harder to read. But let me solve the actual problem: if it's timing rather than the decision, sign this month with a deferred start so the invoice lands in the new fiscal year and off every practice head's current P&L." Then find out what you're really selling against: "What has to be true in the numbers for the freeze to lift?" |
| “"Send me the revised quote and I'll circulate it to the partner group ahead of the meeting."” | That's a graveyard and you both know it — twelve partners, twelve opinions, no owner. "I'll send it today. But a quote that arrives cold in a partner inbox gets read as a cost, not a case. Which single practice head has the worst proposal turnaround problem right now — whose deals are going to boutiques on speed? Give me twenty minutes with them before the 21st and let them present the pilot number in the meeting. A partner walking their own utilization number into that room beats anything I can put in a PDF." |
| “"What we sell is our people's judgment. If I'm paying premium pricing for something that industrialises proposals, I'm paying to commoditize us."” | Meet it head-on rather than softening the price. "The judgment isn't in retyping the qualifications section or rebuilding the staffing table for the fourth time this quarter. It's the client-specific hypothesis on page three, and right now your partners are arriving at that page tired. Every hour spent on assembly is an hour not spent on the part that actually wins the work. I'd argue this pushes more partner time toward judgment, not less — and that's precisely why I'm not going to discount the platform line to look reasonable." |
Questions reps ask about this call
- How do I handle "we budgeted half that" from a COO at a partnership?
Don't counter with a number. Ask how it was built: "Is that a line the CFO has approved, or is it what you think the practice heads will stomach?" At a partnership the answer is usually the second, which means the problem is internal allocation across practice P&Ls, not affordability. That's solvable without margin — phase the rollout, defer the start into the next partner comp year, or get the practice head with the worst RFP-to-submission time to present the pilot number themselves. If the number turns out to be real and approved, move scope, not price: price the two-practice version out loud and let them look at what it doesn't do.
- They dangled their firm's logo as a discount lever, then GC blocked it. What now?
Take the discount back out, warmly and immediately. "That's completely fair — let's take the case study out of the deal, and the points attached to it come out with it." The mistake is letting confidentiality quietly delete your side of the trade while the discount survives. Swap in something GC can live with: unattributed reference calls to named firm profiles, a private analyst briefing, or an intro to their international arm. And engage the risk partner or General Counsel directly in a follow-up rather than trying to clear it through the COO — in professional services that conversation always happens eventually, so run it early and on your terms.
- What should I trade for in a professional services deal specifically?
The usual list — multi-year term, annual invoice in advance, signature date, references — plus a few that are specific to firms. Ask for firm-wide rather than single-practice deployment, because partner autonomy means practice-by-practice adoption is where these rollouts die of polite non-adoption. Ask for a named executive sponsor at Managing Partner or COO level who will open the partners' meeting. Ask for access to prior SOWs and closeout decks for ingestion, which makes the product work and makes you harder to rip out. And ask for the intro to the sister practice or the overseas office while the goodwill is fresh.
- They want to push signature past the partner compensation year. Should I discount to hold the quarter?
No — solve it structurally instead. In a partnership, "push it to next quarter" is almost always about not putting a new cost line against this year's distributions, not about doubting the decision. A deferred start — sign now, first invoice on the first day of their new fiscal year — gives them exactly what they want at zero cost to you. Before you offer it, make them do the cost-of-delay math out loud in their own metrics: the bench days that come back if pursuit support gets unstaffed, and the spring RFP calendar that doesn't move regardless of when they sign.
- How do I respond when they say they'll just build it internally with bench consultants?
Take it seriously and then ask two questions. Who maintains it in eighteen months, when the analysts who built it are staffed and the person who wrote the logic has left for industry — because that is the exact lifecycle of the SharePoint folders they're complaining about. And what does that team not do while they build it? Bench consultants disappearing into internal IP development is one of the reasons the staffing picture is unreliable in the first place. Then hold price and move scope: offer a phased rollout by practice rather than a cheaper firm-wide licence.
- What do I do when the buyer names a number and then goes completely silent?
Nothing, for about seven seconds. Then ask a question — never offer a number. "What's your reaction if I tell you I can't do that?" or "Set the number aside for a moment: once we agree it, does the Managing Partner sign, or does it go to the executive committee?" The rule to memorise is that you may not improve your own offer twice in a row. The silence is deliberate and the buyer is comfortable in it; every deal that leaks thirty points leaks them in that pause. Practise sitting through it out loud before the call, because reading about it and doing it are different skills.